GC
SNY icon

Guggenheim Capital’s Sanofi SNY Stock Holding History

Guggenheim Capital’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$337K Buy
7,000
+154
+2% +$7.18K ﹤0.01% 1338
2025
Q4 		$332K Buy
6,846
+1,586
+30% +$78.6K ﹤0.01% 1479
2025
Q3 		$248K Sell
5,260
-1,439
-21% -$69.4K ﹤0.01% 1450
2025
Q2 		$324K Sell
6,699
-2,351
-26% -$120K ﹤0.01% 1372
2025
Q1 		$502K Buy
9,050
+2,932
+48% +$159K ﹤0.01% 1198
2024
Q4 		$295K Buy
+6,118
New +$311K ﹤0.01% 1459
2024
Q3 		– Sell
-7,652
Closed -$371K – 1935
2024
Q2 		$371K Buy
+7,652
New +$369K ﹤0.01% 1565
2023
Q2 		– Sell
-6,201
Closed -$337K – 1939
2023
Q1 		$337K Buy
+6,201
New +$302K ﹤0.01% 1645
2022
Q4 		– Sell
-9,913
Closed -$377K – 1983
2022
Q3 		$377K Sell
9,913
-7,746
-44% -$345K ﹤0.01% 1588
2022
Q2 		$884K Sell
17,659
-10,445
-37% -$554K 0.01% 1283
2022
Q1 		$1.44M Sell
28,104
-3,917
-12% -$202K 0.01% 1190
2021
Q4 		$1.6M Sell
32,021
-779
-2% -$38.5K 0.01% 1167
2021
Q3 		$1.58M Sell
32,800
-252
-0.8% -$12.8K 0.01% 1173
2021
Q2 		$1.74M Buy
33,052
+998
+3% +$52.1K 0.01% 1172
2021
Q1 		$1.59M Buy
32,054
+493
+2% +$23.7K 0.01% 1152
2020
Q4 		$1.53M Buy
31,561
+1,319
+4% +$65.1K 0.01% 1108
2020
Q3 		$1.52M Buy
30,242
+965
+3% +$49.7K 0.01% 1010
2020
Q2 		$1.5M Buy
29,277
+1,371
+5% +$66.6K 0.01% 1012
2020
Q1 		$1.22M Buy
27,906
+2,919
+12% +$140K 0.01% 1008
2019
Q4 		$1.25M Sell
24,987
-4,173
-14% -$195K 0.01% 1248
2019
Q3 		$1.35M Sell
29,160
-2,624
-8% -$113K 0.01% 1180
2019
Q2 		$1.38M Sell
31,784
-35,733
-53% -$1.52M 0.01% 1206
2019
Q1 		$2.99M Buy
67,517
+196
+0.3% +$8.4K 0.02% 889
2018
Q4 		$2.92M Sell
67,321
-14,072
-17% -$621K 0.02% 847
2018
Q3 		$3.64M Sell
81,393
-3,957
-5% -$169K 0.02% 908
2018
Q2 		$3.42M Sell
85,350
-1,479
-2% -$58.2K 0.02% 935
2018
Q1 		$3.48M Buy
86,829
+19,314
+29% +$804K 0.01% 1242
2017
Q4 		$2.9M Buy
67,515
+11,511
+21% +$531K 0.01% 1384
2017
Q3 		$2.79M Buy
56,004
+12,987
+30% +$628K 0.01% 1433
2017
Q2 		$2.06M Buy
43,017
+19,675
+84% +$940K 0.01% 1600
2017
Q1 		$1.06M Buy
23,342
+1,784
+8% +$75.7K ﹤0.01% 2076
2016
Q4 		$872K Buy
21,558
+311
+1% +$12.3K ﹤0.01% 2214
2016
Q3 		$811K Sell
21,247
-3,610
-15% -$145K ﹤0.01% 2187
2016
Q2 		$1.04M Sell
24,857
-12,150
-33% -$498K ﹤0.01% 2040
2016
Q1 		$1.49M Sell
37,007
-5,706
-13% -$229K ﹤0.01% 1784
2015
Q4 		$1.82M Buy
42,713
+9,308
+28% +$428K 0.01% 1681
2015
Q3 		$1.58M Buy
33,405
+5,887
+21% +$300K ﹤0.01% 1764
2015
Q2 		$1.36M Buy
27,518
+6,670
+32% +$338K ﹤0.01% 2048
2015
Q1 		$1.03M Buy
20,848
+8,024
+63% +$384K ﹤0.01% 2218
2014
Q4 		$585K Buy
12,824
+6,719
+110% +$326K ﹤0.01% 2466
2014
Q3 		$344K Sell
6,105
-8,543
-58% -$459K ﹤0.01% 2682
2014
Q2 		$779K Sell
14,648
-11,096
-43% -$589K ﹤0.01% 2397
2014
Q1 		$1.35M Sell
25,744
-19,624
-43% -$993K ﹤0.01% 2062
2013
Q4 		$2.43M Sell
45,368
-136,633
-75% -$7.05M 0.01% 1601
2013
Q3 		$9.21M Buy
182,001
+93,524
+106% +$4.76M 0.03% 869
2013
Q2 		$4.56M Buy
+88,477
New +$4.71M 0.02% 1095

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Guggenheim Capital's SNY Position: Q1 2026 in Review

Guggenheim Capital increased its Sanofi (SNY) stake by 2.2% in Q1 2026, buying an estimated $7.18K and bringing the position to 7,000 shares worth $337K. The position accounts for ﹤0.01% of the portfolio, ranked #1338.

Guggenheim Capital first reported a position in SNY in Q2 2013 and has held it in 46 quarters since. The position peaked at $9.21M in Q3 2013. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Guggenheim Capital held 7,000 shares of Sanofi worth $337K as of Q1 2026.
  • Guggenheim Capital bought 154 Sanofi shares in Q1 2026, an estimated $7.18K.
  • Sanofi made up ﹤0.01% of Guggenheim Capital's portfolio in Q1 2026, its #1338 holding.
  • Guggenheim Capital first reported a position in Sanofi in Q2 2013 and has held it in 46 quarters since.
  • Guggenheim Capital's Sanofi position peaked at $9.21M in Q3 2013.
  • 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Guggenheim Capital's 13F filing for Q1 2026, filed 15 May 2026.